Skip to content
10-Q

Quarterly Report

Impact BioMedical, INC. IBO

0001641172-25-023809

← back to feed
Filed
Aug 14, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 5, 2025 12.19M sh
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$1.38M
Operating Cash Flow restated Q2 2025 · Jun 30, 2024 −$867K
Cash And Equivalents Q2 2025 · Jun 30, 2025 $624K
Cash And Equivalents Q2 2025 · Dec 31, 2024 $2M
Stockholders Equity Q2 2025 · Jun 30, 2025 −$10.34M
Stockholders Equity Q2 2025 · Dec 31, 2024 $4.26M
Current Liabilities Q2 2025 · Jun 30, 2025 $23.17M
Current Liabilities Q2 2025 · Dec 31, 2024 $9.79M
Total Liabilities Q2 2025 · Jun 30, 2025 $26.44M
Total Liabilities Q2 2025 · Dec 31, 2024 $13.05M
Current Assets Q2 2025 · Jun 30, 2025 $1.48M
Current Assets Q2 2025 · Dec 31, 2024 $2.45M
Total Assets Q2 2025 · Jun 30, 2025 $19.06M
Total Assets Q2 2025 · Dec 31, 2024 $20.29M
Eps Diluted Q2 2025 · Jun 30, 2025 −$1.18
Eps Diluted Q2 2025 · Jun 30, 2025 −$1.29
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.09
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.18
Eps Basic Q2 2025 · Jun 30, 2025 −$1.18
Eps Basic Q2 2025 · Jun 30, 2025 −$1.29
Eps Basic Q2 2025 · Jun 30, 2024 −$0.09
Eps Basic Q2 2025 · Jun 30, 2024 −$0.18
Sga Expense Q2 2025 · Jun 30, 2025 $246K
Sga Expense Q2 2025 · Jun 30, 2025 $495K
Sga Expense Q2 2025 · Jun 30, 2024 $145K
Sga Expense Q2 2025 · Jun 30, 2024 $292K
Rd Expense Q2 2025 · Jun 30, 2025 $75K
Rd Expense Q2 2025 · Jun 30, 2025 $178K
Rd Expense Q2 2025 · Jun 30, 2024 $121K
Rd Expense restated Q2 2025 · Jun 30, 2024 $304K
Net Income Q2 2025 · Jun 30, 2025 −$14.35M
Net Income Q2 2025 · Jun 30, 2025 −$15.61M
Net Income Q2 2025 · Jun 30, 2024 −$889K
Net Income restated Q2 2025 · Jun 30, 2024 −$1.85M
Operating Income Q2 2025 · Jun 30, 2025 −$1.15M
Operating Income Q2 2025 · Jun 30, 2025 −$2.17M
Operating Income Q2 2025 · Jun 30, 2024 −$626K
Operating Income Q2 2025 · Jun 30, 2024 −$1.4M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $11K
Cost Of Revenue Q2 2025 · Jun 30, 2025 $11K
Revenue Q2 2025 · Jun 30, 2025 $7K
Revenue Q2 2025 · Jun 30, 2025 $7K